AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
.jpg)
Source: JomNicha, Shutterstock
- Market capitalisation is one of the simpler metrices to determine which stocks valuation is increasing or decreasing with respect to the market movement.
- Unilever Plc, AstraZeneca Plc, and BHP Plc are among the top 10 FTSE 100 companies according to market capitalisation.
The FTSE 100index includes the top 101 stocks that are listed on the London Stock Exchange. It includes big names, such as AstraZeneca Plc, British American Tobacco Plc, Barclays Plc, and 3i Group Plc, among others.
Market capitalisation is a way of determining a company’s value in the market and is defined as the market value of all its outstanding shares. To arrive at a company’s market capitalisation, the total number of outstanding shares gets multiplied by a single share’s present market value.
Market capitalisation, or mCap, is one of the simpler metrices to determine which stocks valuation is increasing or decreasing with respect to the market movement.
Here is a look at the top 10 FTSE 100 companies based on market capitalisation:
Unilever Plc (LON: ULVR)
The company’s underlying operating profit for 2020 was at €9,367 million, against €9,947 million in 2019. Its underlying EBITDA for 2020 was at €11,385 million, against €11,911 million a year ago. The company’s turnover in 2020 decreased by 2.4 per cent to €50.7 billion in 2020 against €52 billion in 2019.
CEO Alan Jope said that the company operational excellence was driven by focusing on fundamentals of growth and which resulted in the company winning market share in more than 60 per cent of its business in the last quarter.
It maintained dividend through the year, and it was increased by 4 per cent in the fourth quarter to €0.4268 per share.
Also read: Unilever Plc (LON:ULVR) reiterates its wider inclusivity drive, stocks marginally in the red.
The shares of the company were trading at GBX 3,987, up by 0.94 per cent on 15 March at 10:40 GMT+1 and had a market capitalisation of £103,855 million.
AstraZeneca Plc (LON:AZN)
Copyright © 2021 Kalkine Media Pty Ltd.
The FTSE 100 company is at the forefront of the Covid-19 vaccination drive and reported that its total revenue for FY20 was $26,617 million against $24,384 million in FY19, increasing 9 per cent. The company’s operating profit in FY20 was $5,162 million against $2,924 million, up by 77 per cent. It reported a profit after tax of $3,144 million in FY20 against $1,227 million in FY19.
CEO Pascal Soriot had said that the progress of the Covid-19 vaccine along with progress in the company’s pipeline helped in strengthening the company’s performance. He also said that the acquisition of Alexion would help in accelerating the company’s scientific and commercial evolution.
The board of the company has said that it was committed to progressive dividend policy and declared a second interim dividend worth $1.90 per share, and the full year per share dividend was left unchanged at $2.80.
The company had a market capitalisation of £91,247 million and was trading at GBX 6,956, up by 0.07 per cent on 15 March at 10:42 GMT+1.
Also read: Top 5 Growth Stocks One Should Be Exploring in March
HSBC Holdings Plc (LON: HSBA)
Copyright © 2021 Kalkine Media Pty Ltd.
The British multinational investment bank’s reported revenue was worth $50,429 million for FY20, against $56,098 million a year ago. The company’s reported profit after tax came in at $6,099 million in FY20 against $8,708 million in FY19.
Group CEO Noel Quinn said that the company had a solid financial performance, especially in Asia, in the backdrop of the pandemic and this would lay the foundation of its future growth. The company’s growth plans would focus on making HSBC as a bank with a digital-first mindset and a global bank capable of delivering good returns to investors.
The board announced that an interim dividend worth $0.15 per ordinary share for 2020 would to be paid in cash.
HSBC’s shares were trading at GBX 426.45, down by 0.53 per cent on 15 March at 10:43 GMT+1 and had a market capitalisation of £87,259.84 million.
Rio Tinto Plc (LON:RIO)
Copyright © 2021 Kalkine Media Pty Ltd.
The mining giant recently embroiled in a controversy over the company’s alleged role in destroying indigenous sites in Australia reported an underlying EBITDA of $23,902 million in FY20, increasing 13 per cent from $21,197 million in FY19. The total dividend per share increased 26 per cent in FY20 to $557 cents from $443 cents in FY19.
Rio Tinto CEO Jakob Stausholm said that strong commodity prices helped it in delivering an increased EBITDA in 2020. He also said that the new leadership is committed to bring out the company’s full potential.
The company had a market capitalisation of £71,679.33 million and was trading at GBX 5,700, down by 0.78 per cent on 15 March at 10:44 GMT+1.
Diageo Plc (LON:DGE)
The alcohol beverage multinational reported net sales worth £6,874 million in six months ended 31 December 2020 against £7,200 million in the same period a year ago. Its operating profit came in at £2,239 million against £2,442 million a year ago. It declared an interim dividend of 27.96 pence against 27.41 pence a year ago.
The company CEO Ivan Menezes said that North America performed better than the expectation and said that consumer sentiment was largely resilient and the spirits segment continued gaining in the total alcohol beverage pie.
The company was trading at GBX 3,022, up by 0.83 per cent on 15 March at 10:45 GMT+1 and had a market capitalisation of £70,136 million.
BP Plc (LON:BP)
Copyright © 2021 Kalkine Media Pty Ltd.
For FY20, the company reported an underlying RC loss of $5,690 million against a profit of $9,990 million a year ago.
CEO Bernard Looney said that the underlying replacement cost profit for the fourth quarter was $0.1 billion, which was like previous quarter performance and said that performance was affected by lower marketing performance in the Downstream.
He added that volumes remained under pressure because of the pandemic and that FY20 loss was because of lower prices of oil and gas, poor demand, big exploration write-offs and refining margins. The company announced 5.25 cents per share dividend for the quarter.
For the fourth quarter of 2020, the interim dividend to be paid would be worth $0.0525 per ordinary share and would be paid on 26 March, 2021.
The company had a market capitalisation of £65,813.09 million and was trading at GBX 321, down by 0.71 per cent on 15 March at 10:46 GMT+1.
Royal Dutch Shell Plc (LON:RDSA)
Copyright © 2021 Kalkine Media Pty Ltd.
The company reported revenue of $18.05 million for FY20, against $34.48 million a year ago. For the full year, it reported a loss $26,966 million against a profit of $25,485 million in FY19. For the full year, it declared a dividend of $0.6530 per share, against $1.88 per share dividend in 2019. The total dividend declared in the fourth quarter was $1.3 billion. The board said that it expects the interim dividend for the first quarter of 2021 would be $0.1735 per share, a jump of 4 per cent against the same quarter a year ago.
The company’s market capitalisation was £64,947 million, and the shares were trading at GBX 1,572, down by 0.68 per cent on 15 March at 10:47 GMT+1.
GlaxoSmithKline Plc (LON:GSK)
Copyright © 2021 Kalkine Media Pty Ltd.
The pharmaceutical major reported an operating profit of £7,783 million in FY20, against £6,961 million in FY19. Its profit after tax for FY20 was at £6,388 million, against £5,268 million, increasing 21 per cent.
The board declared the fourth interim dividend for 2020 worth 23 pence per share, same as a year ago. It also said that for 2021, the board plans to keep the dividend at the prevailing level of 80 pence per share.
GSK, in collaboration with Medicago had announced commencing its Phase II-III clinical trials of adjuvanted Covid-19 vaccine candidate.
The company’s market cap was £63,381.50 million, and its shares were trading at GBX 1,263.80, up by 0.32 per cent on 15 March at 10:48 GMT+1.
British American Tobacco Plc (LON:BATS)
Copyright © 2021 Kalkine Media Pty Ltd.
The British tobacco giant has recently announced that it would be buying a 20 per cent stake in Organigram, the Canadian cannabis company. For FY20, the company reported an adjusted profit from operations worth £5,816 million against £5,036 million – a jump of 15.5 per cent. Its adjusted revenue for FY20 was at £4,644 million against £5,153 million a year ago, falling by almost 10 per cent.
The board announced a 215.6 pence per ordinary share interim dividend of 25 pence for the year ended 31 December 2020. This would be payable in quarterly instalments of equal amounts of 53.9 pence per ordinary share on May, August, November, and February 2022.
The shares of the company were trading at GBX 2,662, up by 0.72 per cent on 15 March at 10:50 GMT+1 and had a market capitalisation of £60,648.40 million.
BHP Group Plc (LON:BHP)
For the half year ended 31 December 2020, the group announced an underlying EBITDA of $14,680 million against $12,084 million for the same period a year ago. Its profit from operations was at $9,750 million against $8,314 million for the same period a year ago.
The company announced an interim dividend of 101 cents per share, against 65 cents for the same period a year ago.
The company’s shares were trading at GBX 2,178, down by 0.07 per cent on 15 March at 10:50 GMT+1 and had a market capitalisation of £46,032 million.
Reckitt Benckiser Group Plc (LON:RB)
The consumer goods multinational recently announced the acquisition of US pain-relief brand Biofreeze. For FY20, the company reported a revenue of £13,993 million against £12,846 million a year ago. It reported an operating profit of £2,160 million against a loss of £1,954 million a year ago. Total dividends paid for the year stood at £1,241 million in FY20 against £1,227 in FY19.
The directors have announced a final dividend of 101.6 pence per share for the financial year ended 31 December 2020.
The company had a market capitalisation of £43,963.82 million and its shares were trading at GBX 6,232, up by 1.07 per cent on 15 March at 10:51 GMT+1.
